Indications |
Streptococcus VSS S. pneumoniae, N. gonorrhoeae, Branhamella catarrhalis, E. coli, Klebsiella VSS Serratia VSS Proteus VSS H. Influenzae, the following infection caused by Cefixime susceptibility: bronchitis, bronchiectasis (infection), secondary infection of chronic respiratory diseases, pneumonia, pyelonephritis, cystitis, bacterial urethritis, otitis media, sinusitis. |
Adverse Effects |
>10%: Gastrointestinal: Diarrhea (16%) 2% to 10%: Gastrointestinal: Abdominal pain, nausea, dyspepsia, flatulence, loose stools <2%: Acute renal failure, anaphylactoid reaction, anaphylaxis, angioedema, candidiasis, dizziness, drug fever, eosinophilia, erythema multiforme, facial edema, fever, headache, hepatitis, hyperbilirubinemia, increased blood urea nitrogen, increased serum creatinine, increased serum transaminases, jaundice, leukopenia, neutropenia, prolonged prothrombin time, pruritus, pseudomembranous colitis, seizure, serum sickness-like reaction, skin rash, Stevens-Johnson syndrome, thrombocytopenia, toxic epidermal necrolysis, urticaria, vaginitis, vomitingy. |